Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Transplant Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
4.3. Molecular Assays
4.3.1. PCR-based Molecular Assays
4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Real-Time PCR
4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Sequence-based Primer-PCR
4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Sequence-specific Oligonucleotide-PCR
4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Other PCR-based Molecular Assays
4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sequencing-based Molecular Assays
4.4.1. Sanger Sequencing
4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Next Generation Sequencing
4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Other Sequencing-based Molecular Assays
4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Non-molecular Assays
4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
5.3. Reagents & Consumables
5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Instruments
5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Software and Services
5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
6.3. Diagnostics Application
6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Infectious Disease Testing
6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Histocompatibility Testing
6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Blood Profiling
6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Application
6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
7.3. Solid Organ Transplantation
7.3.1. Kidney Transplantation
7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Liver Transplantation
7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Heart Transplantation
7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Lungs Transplantation
7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Pancreas Transplantation
7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Other Organs Transplantation
7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Stem Cell Transplantation
7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Soft Tissue Transplantation
7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Bone Marrow Transplantation
7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
8.3. Hospitals and Transplant Centers
8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Research and Academic Institutes
8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Independent Reference Laboratories
8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. U.K.
9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. Illumina, Inc.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. F. Hoffmann La-Roche Ltd
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. Abbott
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. QIAGEN
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Bruker
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. BD (Becton, Dickinson and Company)
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Werfen (Immucor, Inc.)
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Bio-Rad Laboratories, Inc.
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Omixon Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives